Annual Report, Notice of AGM & Directorate Change | 12-May-2025 | 07:00 | RNS |
Exercise of Options | 10-Apr-2025 | 07:05 | RNS |
Final results | 10-Apr-2025 | 07:00 | RNS |
AIM Rule 17 and Schedule 2(g) Update | 26-Mar-2025 | 13:51 | RNS |
Notice of Results | 21-Mar-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 07-Mar-2025 | 07:00 | RNS |
Acquisition of Cryostore for up to £3.2m | 27-Feb-2025 | 07:00 | RNS |
£2m hMPV characterisation study contract | 17-Feb-2025 | 07:00 | RNS |
RSV contract signed with Inhalon Biopharma | 03-Feb-2025 | 07:00 | RNS |
Holding(s) in Company | 31-Jan-2025 | 13:24 | RNS |
Holding(s) in Company | 31-Jan-2025 | 07:00 | RNS |
Acquisition: two Clinical Research Units from CRS | 29-Jan-2025 | 07:01 | RNS |
Trading update | 29-Jan-2025 | 07:00 | RNS |
LOI signed for Phase 3 Whooping Cough trial | 27-Jan-2025 | 07:00 | RNS |
£3.2m hLAB project | 21-Jan-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 16.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 30.60 |
52 Week Low | 12.60 |
Volume | 820,150 |
Shares Issued | 687.01m |
Market Cap | £109.92m |
Beta | 0.05 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 3 |
Buy | 4 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 15-May-25 | 18-Apr-24 |
Paid | 11-Jun-25 | 20-May-24 |
Amount | 0.20p | 0.20p |
Time | Volume / Share Price |
16:12 | 1,546 @ 15.75p |
16:05 | 10,000 @ 16.13p |
15:48 | 11,693 @ 15.75p |
15:30 | 6,500 @ 16.13p |
15:30 | 9,611 @ 15.75p |
You are here: research